Gara Jalqabaatti › Dhukkubaa Alzheimer › Washington
Qorannoo klinikaalii Dhukkubaa Alzheimer Washington keessatti
Qorannoo 17 Dhukkubaa Alzheimer f Washington keessatti hirmaatuu jiru.
Magaalota Washington keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Bellevue
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1644, Seattle
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06937229Dominantly Inherited Alzheimer Network (DIAN)
- University of Washington, Seattle
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT00869817A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Northwest Clinical Research Center, Bellevue
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06847321A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- EvergreenHealth Medical Center, Kirkland
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1644, Seattle
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07011732Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamooKaffaltii hirmaatootaaf ibsa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06922188Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Washington Medical Center, Seattle
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
Namoota walitti qabaa jiraSadarkaa 2/3Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
Namoota walitti qabaa jiraSadarkaa 2/3Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Northwest Clinical Research Center, Bellevue
- Universal Research Group, Tacoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- University of Washington Medical Center, Seattle
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT07094516Late Onset Alzheimer's Disease
- University of Washington, Seattle
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT05010603A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- University of Washington, Seattle
Namoota walitti qabaa jira
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 20-Ado-2025 · NCT06411561Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.